Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease

Epidemiology and Infection

Volumn 118, Issue 2, 1997, Pages 155-164

  Von Hertzen, L ^a,d   Alakarppa H ^a   Koskinen, R ^b   Liippo, K ^c   Surcel, H M ^a   Leinonen, M ^a   Saikku, P ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b Laakso Hospital   (Finland)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

^d Finnish Lung Health Association   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

AGED; ANTIBODY TITER; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; POLYMERASE CHAIN REACTION; SPUTUM ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; COMMUNITY-ACQUIRED INFECTIONS; DNA, BACTERIAL; FEMALE; HUMANS; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; POLYMERASE CHAIN REACTION; PREVALENCE; SEVERITY OF ILLNESS INDEX; SPUTUM;

EID: 0030935549     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S095026889600725X     Document Type: Article

References (38)

1. Cosio M, Ghezzo H, Hogg JC, et al. The relations between structural changes in small airways and pulmonary-function tests. N Engl J Med 1978; 298: 1277-81.
2. Wright JL, Lawson LM, Pare PD, Kennedy S, Wiggs B, Hogg JC. The detection of small airways disease. Am Rev Respir Dis 1984; 129: 989-94.
3. Fletcher C, Peto R. The natural history of chronic airway obstruction. BMJ 1977; 1: 1645-8.
4. Yang Z, Cummings PK, Patton DL, Kuo C. Ultrastructural lung pathology of experimental Chlamydia pneumoniae pneumonitis in mice. J Infect Dis 1994; 170: 464-7.
5. Beatty W, Morrison RP, Byrne GI. Persistent Chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbial Rev 1994; 58: 686-99.
6. Numazaki K, Suzuki K, Chiba S. Replication of Chlamydia trachomatis and C. pneumoniae in the human monocytic cell line U-937. J Med Microbiol 1995; 42: 191-5.
7. Schachter J, Chlamydial infections (First of three parts). N Engl J Med 1978; 298: 428-35.
8. Mårdh PA, Paavonen J, Puolakkainen M. Chlamydial infections. New York and London: Plenum Medical Book Company, 1989.
9. Hahn DL, Dodge R, Golubjatnikov R. Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis and adult-onset asthma. JAMA 1991; 266: 225-30.
10. Emre U, Roblin P, Gelling M, et al. The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch Pediatr Adolesc Med 1994; 148: 727-32.
11. Grönhagen-Riska, C, Saikku P, Fröseth B, Grayston T. Antibodies to TWAR - a novel type of chlamydia - in sarcoidosis. In: Grassi C, ed. Sarcoidosis and other granulomatous disorders. Amsterdam: Elsevier Scientific Publications, 1988: 297-301.
12. von Hertzen L, Leinonen M, Surcel H-M, Karjalainen J, Saikku P. Measurement of sputum antibodies in the diagnosis of acute and chronic respiratory infections associated with Chlamydia pneumoniae. Clin Diagn Lab Immun 1995; 2: 454-7.
13. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144: 1202-18.
14. Wang SP, Grayston JT. Immunologic relationship between genital TRIC, lymphogranuloma venerum and related organism in a new microtiter indirect immunofluorescence test. Am J Ophthalmol 1970; 70: 367-74.
15. Jauhiainen T, Tuomi T, Leinonen M, Kark JD, Saikku P. Interference of immunoglobulin G (IgG) antibodies in IgA antibody determination for Chlamydia pneumoniae by micro-immunofluorescence test. J Clin Microbiol 1994; 32: 839-40.
16. Hahn D, Saikku P. Serologic evidence for Chlamydia pneumoniae infection in recently symptomatic asthma: a pilot case-control study. Am J Respir Crit Care Med 1995; 151 (suppl, Second of two parts): A470.
17. Linnanmäki E, Leinonen M, Mattila K, Nieminen MS, Valtonen V, Saikku P. Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease. Circulation 1993; 87: 1130-4.
18. Kuo CC, Grayston JT. A sensitive cell line, HL cells, for isolation and propagation of Chlamydia pneumoniae strain TWAR. J Infect Dis 1990; 162: 755-8.
19. Holland SM, Gaydos CA, Quinn TC. Detection and differentiation of Chlamydia trachomatis, Chlamydia psittaci and Chlamydia pneumoniae by DNA amplification. J Infect Dis 1990; 162: 984-7.
20. Erlich HA, Gelfund D, Sninsky JJ. Recent advances in the polymerase chain reaction. Science 1991; 252: 1643-51.
21. Soini H, Skurnik M, Liippo K, Tala E, Viljanen MK. Detection and identification of mycobacteria by amplification of a segment of the gene coding for the 32-kilodalton protein. J Clin Microbiol 1992; 30: 2025-8.
22. Blasi F, Legnani D, Lombardo VM, et al. Chlamydia pneumoniae infection in acute exacerbations of COPD. Eur Respir J 1993; 6: 19-22.
23. Beaty CD, Grayston T, Wang SP, Kuo CC, Reto CS, Martin TR. Chlamydia pneumoniae, strain TWAR, infection in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1991 ; 144: 1408-10.
24. McComb DE, Nichols RL, Semine DZ, et al. Chlamydia trachomatis in women: antibody in cervical secretions as a possible indicator of genital infection. J Infect Dis 1979; 139: 628-33.
25. Buisman NJ, Ossewaarde JM, Rieffe M, van Loon AM, Stilma JS. Chlamydia keratoconjunctivitis - determination of Chlamydia trachomatis specific secretory immunoglobulin A in tears by enzyme immunoassay. Graefe's Arch Clin Exp Ophthalmol 1992; 230: 411-5.
26. Bass CA, Jungkind DL, Silverman NS, Bond JM. Clinical evaluation of a new polymerase chain reaction assay for detection of Chlamydia trachomatis in endocervical specimens. J Clin Microbiol 1993; 31: 2648-53.
27. Ossewaarde JM, Rieffe M, Rozenberg-Arska M, Ossenkoppele PM, Nawrocki RP, van Loon AM. Development and clinical evaluation of polymerase chain reaction test for detection of Chlamydia trachomatis. J Clin Microbiol 1992; 30: 2122-8.
28. Mahony JB, Luinstra, KE, Sellers JW, et al. Role of confirmatory PCRs in determining performance of Chlamydia Amplicor PCR with endocervical specimens from women with a low prevalence of infection. J Clin Microbiol 1994; 32: 2490-3.
29. von Hertzen L, Isoaho H, Leinonen M, et al. Chlamydia pneumoniae antibodies in chronic obstructive pulmonary disease. Int J Epidemiol 1996; 25: 658-64.
30. Kuo CC, Shor A, Campbell LA, Fukashi H, Patton DL, Grayston T. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 1992; 167: 841-9.
31. Rook GA, Hernandes-Pando R, Lightman SL. Hormones, peripherally activated prohormones and regulation of the Th1/Th2 balance. Immunol Today 1994; 15: 301-3.
32. Kronborg G. Lipopolysaccharide (LPS), LPS-immunecomplexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection. APMIS 1995; 103 (suppl): 5-30.
33. Schachter J. Diagnosis of chronic chlamydial infection. In: Spencer RC, Wright EP, Newsom SW, eds. Rapid methods and automation in microbiology and immunology. Andover, Hampshire, England: Intercept Ltd, 1994: 373-80.
34. Moulder JW. Interaction of chlamydiae and host cells in vitro. Microbiol Rev 1991; 55: 143-90.
35. Kern DG, Neill MA, Schachter J. A seroepidemiologic study of Chlamydia pneumoniae in Rhode Island. Chest 1993; 104: 208-13.
36. Marrie TJ. Chlamydia pneumoniae. Thorax 1993; 48: 1-4.
37. Mendall MA, Carrington D, Strachan D, et al. Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease. J Infect 1995; 30: 121-8.
38. Dahlen GH, Boman J, Birgander LS, Lindblom B. Lp(a) lipoprotein, IgG, IgA and IgM antibodies to Chlamydia pneumoniae and HLA class II genotype in early coronary artery disease. Atherosclerosis 1995; 114: 165-74.